MetaADEDB 2.0 @ LMMD
abacavir, lamivudine drug combination
(UGWQMIXVUBLMAH-IVVFTGHFSA-N)
Structure
SMILES
Nc1ccn(c(=O)n1)[C@@H]1CS[C@@H](O1)CO.OC[C@@H]1C=C[C@@H](C1)n1cnc2c1nc(N)nc2NC1CC1
Molecular Formula:
C22H29N9O4S
Molecular Weight:
515.589
Log P:
1.7336
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
5
TPSA:
217.55
CAS Number(s):
852337-16-7
Synonym(s)
1.
abacavir, lamivudine drug combination
2.
Epzicom
3.
abacavir - lamivudine
4.
abacavir sulfate-lamivudine combination
5.
abacavir-lamivudine combination
External Link(s)
MeSHC492871
PubChem Compound5273759
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Myocardial InfarctionFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
2HypersensitivityFAERS: 10US FAERS
3Cerebrovascular accidentFAERS: 7US FAERS
4ThrombocytopeniaFAERS: 6US FAERS
5PruritusFAERS: 5US FAERS
6VomitingFAERS: 5US FAERS
7Angina PectorisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
8AstheniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Chest PainFAERS: 4US FAERS
10MalaiseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
11NauseaFAERS: 4US FAERS
12Abdominal PainFAERS: 3US FAERS
13ArthralgiaFAERS: 3US FAERS
14Drug ineffectiveFAERS: 3US FAERS
15FatigueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
16MyalgiaFAERS: 3US FAERS
17PalpitationsFAERS: 3US FAERS
18Tablet physical issueFAERS: 3US FAERS
19UrticariaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Weight decreasedFAERS: 3US FAERS
21Cell DeathFAERS: 2US FAERS
22Chest discomfortFAERS: 2US FAERS
23ChillsFAERS: 2US FAERS
24CholestasisFAERS: 2US FAERS
25DizzinessFAERS: 2US FAERS
26ErythemaFAERS: 2US FAERS
27LeukopeniaFAERS: 2US FAERS
28LymphopeniaFAERS: 2US FAERS
29Neutrophil count decreasedFAERS: 2US FAERS
30OverdoseFAERS: 2US FAERS
31PapuleFAERS: 2US FAERS
32Product quality issueFAERS: 2US FAERS
33Stevens-Johnson SyndromeFAERS: 2US FAERS
34Sudden deathFAERS: 2US FAERS
35Thrombocytopenic purpuraFAERS: 2US FAERS
36AcneFAERS: 1US FAERS
37Acute myocardial infarctionFAERS: 1US FAERS
38Adverse eventFAERS: 1US FAERS
39Blood iron decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Blood phosphorus increasedFAERS: 1US FAERS
41Cardiac ArrestFAERS: 1US FAERS
42Cardiac TamponadeFAERS: 1US FAERS
43CardiotoxicityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
44DysuriaFAERS: 1US FAERS
45Eosinophilic PneumoniaFAERS: 1US FAERS
46Feeling abnormalFAERS: 1US FAERS
47Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
48Head discomfortFAERS: 1US FAERS
49HeadacheFAERS: 1US FAERS
50HepatomegalyFAERS: 1US FAERS
51HepatotoxicityFAERS: 1US FAERS
52InfectionFAERS: 1US FAERS
53InflammationFAERS: 1US FAERS
54Lip swellingFAERS: 1US FAERS
55MacrocytosisFAERS: 1US FAERS
56Mental impairmentFAERS: 1US FAERS
57MyelitisFAERS: 1US FAERS
58MyelofibrosisFAERS: 1US FAERS
59Nuchal RigidityFAERS: 1US FAERS
60Oropharyngeal discomfortFAERS: 1US FAERS
61Oropharyngeal painFAERS: 1US FAERS
62PainFAERS: 1US FAERS
63Peripheral swellingFAERS: 1US FAERS
64PneumoniaFAERS: 1US FAERS
65Post procedural strokeFAERS: 1US FAERS
66Respiratory distressFAERS: 1US FAERS
67RhinitisFAERS: 1US FAERS
68Skin lesionFAERS: 1US FAERS
69Suicide attemptFAERS: 1US FAERS
70Transaminases increasedFAERS: 1US FAERS
71Urinary tract infectionFAERS: 1US FAERS
72jaundiceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Anemia14986271CTD
74HIV Infections19542866
20204580
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.